Search Results - "Burmester G"

This result is not displayed to guests.
Login for full access.

NO B CELLS-NO--ACTIVE RA? ADVANCES IN B CELL DEPLETION IN RA--REPEATED THERAPY UNDER CONDITIONS OF CLINICAL PRACTICE.

Authors: Dorner, T. Burmester, G. R.

Source: Romanian Journal of Rheumatology / Revista Romana de Reumatologie. 2008, Vol. 17 Issue 4, p189-192. 4p.

Optimised glucocorticoid therapy: the sharpening of an old spear.

Authors: Buttgereit F Burmester G Lipworth BJ

Source: Lancet. 2/26/2005, Vol. 365 Issue 9461, p801-803. 3p.

RWD69 Healthcare Resource Use by European Patients Enrolled in RA-BE-REAL: 12 Month Data From a Multinational, Prospective, Observational Study of Patients With Rheumatoid Arthritis.

Authors: Alten, R Burmester, G Matucci-Cerinic, M et al.

Source: Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS461-S462. 2p.

Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy.

Authors: Keystone, E. Burmester, G. R. Fume, R. et al.

Source: Arthritis & Rheumatism. Jun2008, Vol. 58 Issue 6, p785-793. 9p. 5 Charts, 3 Graphs.

What is the rank of RANKL in spondylarthritis?

Authors: Loddenkemper, K. Burmester, G.-R.

Source: Arthritis & Rheumatism. Mar2008, Vol. 58 Issue 3, p641-644. 4p.

POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies

Authors: Alten, R Burmester, G Matucci-Cerinic, M et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS221-S221. 1p.

Synovitis score: discrimination between chronic low-grade and high-grade synovitis.

Authors: Krenn, V. Morawietz, L. Burmester, G.-R. et al.

Source: Histopathology. Oct2006, Vol. 49 Issue 4, p358-364. 7p. 2 Color Photographs, 3 Charts, 1 Graph.

Effects of anti-CD4 antibodies on the release of IL-6 and TNF-α in whole blood samples from patients with systemic lupus erythematosus.

Authors: Brink, I. Thiele, B. Burmester, G-R. et al.

Source: Lupus. 1999, Vol. 8 Issue 9, p723-730. 8p.

Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis.

Authors: Eisfeld, H Glimm, AM Burmester, GR et al.

Source: Scandinavian Journal of Rheumatology. Jul2021, Vol. 50 Issue 4, p299-306. 8p.

The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens.

Authors: Egerer K Feist E Burmester G

Source: Deutsches Ärzteblatt International. 3/6/2009, Vol. 106 Issue 10, p159-163. 5p.

URL: 37355123

Cryopreservation of Artificial Cartilage: Viability and Functional Examination after Thawing.

Authors: Lübke, C. Sittinger, M. Burmester, G. -R. et al.

Source: Cells Tissues Organs. 2001, Vol. 169 Issue 4, p368-376. 9p. 2 Color Photographs, 2 Graphs.

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID).

Authors: Witt, M Grunke, M Proft, F et al.

Source: Lupus. Oct2013, Vol. 22 Issue 11, p1142-1149. 8p. 5 Charts, 2 Graphs.

Detailed Joint Region Analysis of the 7-Joint Ultrasound Score: Evaluation of an Arthritis Patient Cohort over One Year.

Authors: Ohrndorf, S. Halbauer, B. Martus, P. et al.

Source: International Journal of Rheumatology. 2013, p1-9. 9p.

Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: An experimental mouse study.

Authors: Enghard, P Grussie, E Rieder, C et al.

Source: Lupus. Dec2011, Vol. 20 Issue 12, p1240-1249. 10p. 1 Color Photograph, 4 Graphs.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Authors: Bramlage, C. P. Kaps, C. Ungethüm, U. et al.

Source: Scandinavian Journal of Rheumatology. Dec2008, Vol. 37 Issue 6, p401-409. 9p. 2 Color Photographs, 5 Graphs.

EFFECTIVENESS OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS IN PATIENTS WITH A HISTORY OF ANTI-TNF ANTAGONIST THERAPY IN CLINICAL PRACTICE.

Alternate Title: Beneficiile adalimumabului la pacienţii cu poliartrita reumatoidӑ trataţi anterior cu agenţi anti-TNF.

Authors: Bomnardieri, S. Ruiz, A. A. Fardellone, P. et al.

Source: Romanian Journal of Rheumatology / Revista Romana de Reumatologie. 2008, Vol. 17 Issue 1, p34-46. 13p. 3 Charts, 2 Graphs.

Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity.

Authors: Jacobi, AM Rohde, W Ventz, M et al.

Source: Lupus. Aug2001, Vol. 10 Issue 8, p554. 8p.

Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus.

Authors: Egerer, K. Feist, E. Rohr, U. et al.

Source: Lupus. 2000, Vol. 9 Issue 8, p614-621. 8p.

PC.01 - L’association abatacept plus méthotrexate permet d’atteindre à nouveau la rémission, de manière efficace et bien tolérée, après reprise du traitement pour poussées inflammatoires chez des patients atteints de polyarthrite rhumatoïde précoce

Authors: Combe, B. Emery, P. Burmester, G. et al.

Source: Revue du Rhumatisme. Nov2016 Supplement 1, Vol. 83, pA43-A44. 1p.